Martin Vogelbaum - Director at Tvardi Therapeutics, Inc.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Martin Vogelbaum since 07 Jul 2025

Reported holdings for Martin Vogelbaum in Tvardi Therapeutics, Inc.

Form 4 holding Director

Cara Therapeutics, Inc.

Security class
Common Stock
Shares / value
411,007
Estimated value
$308,255
Report date
04 Jun 2024
Price
$0.7500
Ownership
Direct
Form 4 holding Director

Cara Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
390,000
Estimated value
Report date
04 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Martin Vogelbaum in Tvardi Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .